The pharmacy received a report of an adverse event from a patient using one of their compounded medications and is issuing this recall as a precautionary measure.
The recalled sterile products, including injectable medications, IVs, eye drops, nasal sprays and inhalation solutions, were distributed between June 17, 2013 and Dec. 17, 2013.
More Articles on Product Recalls:
Alexion Pharmaceuticals Updates Soliris Recall Information
Abbott Recalls Certain Lots of FreeStyle, FreeStyle Lite Blood Glucose Test Strips
FDA Recalls Spacelabs Healthcare’s Anesthesia Workstations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.